MASSACHUSETTS
-
Chris Kelly to Join LineVision's Advisory Board
National Grid's former Chief Operating Officer has spent over 20 years with the utility working to modernize energy delivery BOSTON, April 13, 2022 /PRNewswire/ -- LineVision, Inc., the world's only p…
-
Digital Commerce Leader Salsify Closes $200 Million Investment Led by TPG at $2 Billion Valuation
Permira, Neuberger Berman Funds, and Cap Table Coalition Join Series F Round BOSTON, April 13, 2022 /PRNewswire/ -- Salsify, the Commerce Experience Management (CommerceXM) platform empowering brand m…
-
TetraScience Partners with EPAM to Help Customers Scale Improved Scientific Data Outcomes
Partnership Exemplifies Power of TetraScience's Open Network Ecosystem to Create Enterprise End-to-End Solutions BOSTON, April 13, 2022 /PRNewswire/ --
-
Curaleaf's Select Brand Celebrates 4/20 With Limited-Edition Cliq Elite Live Strain in California
"Haunted Haze" was developed in collaboration with acclaimed Los Angeles artist James Haunt WAKEFIELD, Mass., April 13, 2022 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF)...
-
ValueMomentum Achieves Mendix Global Systems Integrator Status
Expanded Partnership Will Accelerate Go-To-Market Capabilities ValueMomentum is expanding its cloud presence with Mendix Global Industry Cloud for Insurance and Financial ServicesFinancial services an…
-
Fresenius Medical Care Launches My Reason® Campaign to Enroll Patients in Groundbreaking Renal-focused Genomic Registry
Goal of 100,000 Participants Within Five Years to Help Scientists Better Understand Genetic Variations in Patients with Chronic Kidney Disease WALTHAM, Mass., April 13, 2022 /PRNewswire/ -- Fresenius…
-
AXCELIS ANNOUNCES TIMING AND AVAILABILITY OF FIRST QUARTER 2022 RESULTS AND CONFERENCE CALL
BEVERLY, Mass., April 13, 2022 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) will release financial results for the first quarter 2022 on Wednesday, May 4, 2022 at 4:00 p.m. Eastern Time (…
-
Akamai Technologies To Hold First Quarter 2022 Investor Conference Call On Tuesday, May 3, at 4:30 PM ET
CAMBRIDGE, Mass., April 13, 2022 /PRNewswire/ -- Akamai Technologies, Inc. (NASDAQ: AKAM), announced today that the company will hold a conference call for investors on Tuesday, May 3, 2022, at 4:30 p…
-
Lyra Therapeutics Announces Closing of $100.5 Million Private Placement
Private placement priced at-the-market under Nasdaq rules Proceeds to support Lyra's ongoing clinical development of LYR-210 and LYR-220 Proceeds, combined with existing cash and expected milestone pa…
-
Adiso Therapeutics Announces Completion of First Cohort Enrollment in a Phase 1b Study of ADS051 for the Treatment of Moderately-to-Severely Active Ulcerative Colitis
CONCORD, Mass., April 13, 2022 /PRNewswire/ -- Adiso Therapeutics, Inc., a clinical-stage biotechnology company developing novel medicines targeting chronic inflammatory diseases, today announced that…
-
Cardiff Oncology Announces Departure of Chief Medical Officer
SAN DIEGO, April 12, 2022 /PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers,…
-
XSET Acquihires Astoic Management; Appoints Co-Founders to Executive Roles
Astoic Management has represented talent including Offset, Floyd Mayweather, and Ronnie2K BOSTON, April 12, 2022 /PRNewswire/ -- XSET, the world's fastest-growing gaming and lifestyle...
-
Burns & Levinson Announces Andrea Dunbar Rejoins Private Client Group
BOSTON, April 12, 2022 /PRNewswire/ -- Burns & Levinson announced today that
-
Entrinsic Bioscience Announces Tool with Potential for Development of New Therapies Addressing Constipation
NORWOOD, Mass., April 12, 2022 /PRNewswire/ -- Entrinsic Bioscience (EBS) announces a tool to measure intestinal peristalsis that could lead to the development of therapeutic agents for constipation,…
-
Entrinsic Bioscience Steps Closer to Amino Acid Formulation as Therapy for Cystic Fibrosis
NORWOOD, Mass., April 12, 2022 /PRNewswire/ -- Entrinsic Bioscience and its licensee Nuvara Therapeutics announces they are one step closer to using RxAA formulations as a therapy for patients with Cy…
-
Private Equity Finance Partner Joins Latham & Watkins in Boston
Susan Yoon Parker advises private equity sponsors, investment funds, and operating companies on a variety of financing transactions. BOSTON, April 12, 2022 /PRNewswire/ -- Latham & Watkins LLP1 is ple…
-
CREF Appoints Former PwC Health Care Leader Ryan Hayden, Chief Digital & Strategy Officer
Company commits to accelerated development of industry leading software platform to support the next generation of sustainable, smart building real estate solutions. BOSTON, April 12, 2022 /PRNewswire…
-
Hometap Expands Home Equity Investment Option to Homeowners in Nevada
Silver State Homeowners Gain Access to Debt-Free Alternative for Tapping Growing Home Equity BOSTON, April 12, 2022 /PRNewswire/ -- Hometap, which provides a smart, new loan alternative for tapping in…
-
Akamai Named a Bot Management Leader by Independent Research Firm
Customers Cite Akamai's "Outstanding Job of Identifying New and Emerging Threats and Adapting Their Response." CAMBRIDGE, Mass., April 12, 2022 /PRNewswire/ -- Akamai Technologies, Inc. (NASDAQ: AKAM)…
-
110 Grill® Supports Boston Children's Hospital Celiac Disease Program
Allergy Friendly Restaurant Brand Grows Gluten Free Education Around Safe Dining and Food Insecurity WESTFORD, Mass., April 12, 2022 /PRNewswire/ -- 110 Grill®, New England's fastest growing allergy f…